Tumor Biology

, Volume 37, Issue 9, pp 12403–12410 | Cite as

Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3β signaling in gastric cancer

  • Jin Dai
  • Chenchen Qian
  • Mingli Su
  • Minhu Chen
  • Jie Chen
Original Article


Epithelial-mesenchymal transition (EMT) plays an important role in metastasis of gastric cancer. Our previous study showed that Gastrokine-2 (GKN2) can inhibit the metastasis of SGC-7901 and AGS cells. Herein, we further explored the role of GKN2 in epithelial mesenchymal transition of gastric cancer cells and the underlying mechanisms. We found that overexpression of GKN2 can lower the protein expression level of Snail and markedly elevate E-cadherin protein level in SGC7901 and AGS cells. Further data showed that knockdown of snail can inhibit the migration and invasion of SGC-7901 and AGS cells. It is known that Snail can be phosphorylated by GSK3β, a downstream protein of PI3K/AKT pathway. We then test protein expression of p-GSK3β(Ser-9), the downstream protein of PI3K/AKT, which was significantly decreased under the circumstance of GKN2 overexpression. Moreover, LY294002, a PI3K inhibitor, can reverse the protein expression change of E-cadherin and snail induced by siGKN2. Taken together, these findings suggested that GKN2 suppressed epithelial mesenchymal transition of gastric cancer cells by downregulation of snail through PI3K/AKT/GSK3β signaling pathway.


Gastrokine-2 Gastric cancer Metastasis Epithelial mesenchymal transition 



This study was supported by grants from the National Natural Science Foundation of China (No. 30871145 and 81072048).

Compliance with ethical standards

Conflict of interests


Supplementary material

13277_2016_5107_MOESM1_ESM.pdf (38 kb)
ESM 1 (PDF 37 kb)


  1. 1.
    Lordick F et al. Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev. 2014;40:692–700.CrossRefPubMedGoogle Scholar
  2. 2.
    Jemal A et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6:449–58.CrossRefPubMedGoogle Scholar
  4. 4.
    Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39:305–18.CrossRefPubMedGoogle Scholar
  5. 5.
    Bernards R, Weinberg RA. A progression puzzle. Nature. 2002;418:823.CrossRefPubMedGoogle Scholar
  6. 6.
    Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.CrossRefPubMedGoogle Scholar
  7. 7.
    Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265–73.CrossRefPubMedGoogle Scholar
  8. 8.
    Le Bras GF, Taubenslag KJ, Andl CD. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh Migr. 2012;6:365–73.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Thiery JP. Epithelial-mesenchymal transitions in cancer onset and progression. Bull Acad Natl Med. 2009;193:1969–78. 1978-9.PubMedGoogle Scholar
  10. 10.
    Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415–28.CrossRefPubMedGoogle Scholar
  11. 11.
    Hedlund J, Johansson J, Persson B. BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Notes. 2009;2:180.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Menheniott TR, Kurklu B, Giraud AS. Gastrokines: stomach-specific proteins with putative homeostatic and tumor suppressor roles. Am J Physiol Gastrointest Liver Physiol. 2013;304:109–21.CrossRefGoogle Scholar
  13. 13.
    Moss SF et al. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res. 2008;14:4161–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Dai J et al. Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis. Tumour Biol. 2014;35:4199–207.CrossRefPubMedGoogle Scholar
  15. 15.
    Westley BR, Griffin SM, May FE. Interaction between TFF1, a gastric tumor suppressor trefoil protein, and TFIZ1, a brichos domain-containing protein with homology to SP-C. Biochemistry. 2005;44:7967–75.CrossRefPubMedGoogle Scholar
  16. 16.
    Resnick MB et al. Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut. 2006;55:1717–24.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Du JJ et al. Down-regulated full-length novel gene GDDR and its effect on gastric cancer. Zhonghua Yi Xue Za Zhi. 2003;83:1166–8.PubMedGoogle Scholar
  18. 18.
    Yoon JH et al. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol. 2011;137:1697–704.CrossRefPubMedGoogle Scholar
  19. 19.
    Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001;359:1–16.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol. 2005;27:1677–83.PubMedGoogle Scholar
  21. 21.
    Cano A et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76–83.CrossRefPubMedGoogle Scholar
  22. 22.
    Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res. 2014;33:62.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Shin NR et al. Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. BMC Cancer. 2012;12:521.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Zhou BP et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6:931–40.CrossRefPubMedGoogle Scholar
  26. 26.
    Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 2005;24:7443–54.CrossRefPubMedGoogle Scholar
  27. 27.
    Harwood AJ. Regulation of GSK-3: a cellular multiprocessor. Cell. 2001;105:821–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Wu Y et al. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell. 2009;15:416–28.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res. 2006;66:3963–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129:1261–74.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Kim D et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 2001;15:1953–62.CrossRefPubMedGoogle Scholar
  32. 32.
    Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003;116:1175–86.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  1. 1.Department of GastroenterologyThe First Affiliated Hospital, Sun Yat-Sen UniversityGuangzhouChina
  2. 2.Division of GastroenterologyGuizhou Provincial People’s HospitalGuiyangChina

Personalised recommendations